Science Explorer Interactive view Map
Research facility · Paris · ??

THERANOSCAN : Biomarqueurs Théranostiques des Cancers Bronchiques Non à Petites Cellules

sante.sorbonne-universite.fr/structures-de-recherche/grc-4-theranoscanROR OpenAlex
Research works
35
▼ 18% vs 2013–17
Citations
511
14.6 per fractional work
Top-10% rate
12.4%
record average 16.5%
Open access
34%
world 28%

Not ranked overall: THERANOSCAN : Biomarqueurs Théranostiques des Cancers Bronchiques Non à Petites Cellules is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.36× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.01× its world share, 0 worksImmunology and Micro…Neuroscience: 1.42× its world share, 0 worksNeuroscienceChemistry: 0.13× its world share, 0 worksChemistryEnvironmental Science: 0.15× its world share, 0 worksEnvironmental ScienceMathematics: 0.44× its world share, 0 worksMathematicsHealth Professions: 0.25× its world share, 0 worksHealth ProfessionsMedicine: 4.15× its world share, 5 worksMedicineEconomics, Econometrics and Finance: 0.31× its world share, 0 worksEconomics, Econometr…Psychology: 0.47× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.

Which keywords describe research at THERANOSCAN : Biomarqueurs Théranostiques des Cancers Bronchiques Non à Petites Cellules?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Chemotherapy, Clinical Trials, Treatment Guidelines, ALK Inhibitors, EGFR Mutations, Adjuvant Therapy and Prognostic Factors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Targeted Therapy8▲ 111×4 topics
  2. Chemotherapy8▲ 33×14 topics
  3. Clinical Trials8▲ 35×6 topics
  4. ALK Inhibitors5▲ 268×1 topic
  5. EGFR Mutations5▲ 268×1 topic
  6. Treatment Guidelines5▲ 70×2 topics
  7. Adjuvant Therapy4▲ 97×2 topics
  8. Prognostic Factors3▲ 21×6 topics
  9. Radiotherapy3▲ 25×4 topics
  10. Molecular Profiling3▲ 78×3 topics
  11. CT Screening3▲ 151×1 topic
  12. Lung Cancer3▲ 51×1 topic
  13. Metastasis3▲ 25×6 topics
  14. Immunohistochemistry3▲ 82×3 topics
  15. Tumor Microenvironment3▲ 22×4 topics
  16. Immunotherapy3▲ 12×8 topics
  17. Therapeutic Targets2▲ 29×2 topics
  18. Breast Cancer2▲ 23×6 topics
  19. Biomarkers2▲ 10×5 topics
  20. Genomic Profiles2▲ 168×1 topic
  21. Immunosuppression2▲ 51×3 topics
  22. Prognostic Markers2▲ 62×3 topics
  23. Small-Cell Lung Cancer2▲ 168×1 topic
  24. Lung Tumors2▲ 264×1 topic
  25. Metastatic Carcinomas2▲ 264×1 topic
  26. PET Imaging2▲ 27×4 topics
  27. Cancer2▲ 3.6×19 topics
  28. Immune Checkpoint Blockade2▲ 84×1 topic
  29. PD-1 and PD-L12▲ 84×1 topic
  30. Cancer Incidence2▲ 31×4 topics
  31. Clinical Practice Guidelines1▲ 6.9×5 topics
  32. Molecular Characterization1▲ 22×5 topics
  33. Precision Medicine1▲ 13×4 topics
  34. Angiogenesis1▲ 8.8×3 topics
  35. Cetuximab1▲ 46×2 topics
  36. Fluorouracil1▲ 100×1 topic
  37. Gene Expression Profiling1▲ 37×2 topics
  38. KRAS Mutations1▲ 100×1 topic
  39. Molecular Subtypes1▲ 39×2 topics
  40. Endoscopic Resection1▲ 32×2 topics

Which research topics does THERANOSCAN : Biomarqueurs Théranostiques des Cancers Bronchiques Non à Petites Cellules publish most on?

By volume in 2022–2025: Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Radiopharmaceutical Chemistry and Applications and Cancer Genomics and Diagnostics.

Lung Cancer Treatments a…1Lung Cancer Treatments and Mutations: 1 fractional worksLung Cancer Research Studies: 0 fractional worksRadiopharmaceutical Chemistry and Applications: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksLung Cancer Diagnosis and Treatment: 0 fractional worksLiver physiology and pat…0Liver physiology and pathology: 0 fractional worksCancer, Stress, Anesthes…0Cancer, Stress, Anesthesia, and Immune Response: 0 fractional worksColorectal Cancer Treatm…0Colorectal Cancer Treatments and Studies: 0 fractional worksMelanoma and MAPK Pathways: 0 fractional worksCancer-related molecular mechanisms research: 0 fractional works
Pulmonary and Respiratory MedicineOncologyRadiology, Nuclear Medicine and ImagingCancer Research3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  2. 2 Lung Cancer Research Studies Oncology 0 works
  3. 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 0 works
  5. 5 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  6. 6 Liver physiology and pathology Hepatology 0 works
  7. 7 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 0 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 0 works
  9. 9 Melanoma and MAPK Pathways Molecular Biology 0 works
  10. 10 Cancer-related molecular mechanisms research Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.8%not open66.2%

World: 28% of research is openly available.

with international co-authors11.3%domestic only88.7%

World: 19% is written across borders.

How has THERANOSCAN : Biomarqueurs Théranostiques des Cancers Bronchiques Non à Petites Cellules's research output changed?

Output in 2018–2022 was 18% lower than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Paris

All research institutions in Paris

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.